ADI-PEG-20

BIOLOGICAL2 trials

Sponsors

Global Coalition For Adaptive Research Inc., University of Miami

Conditions

Melanoma (Skin)Oncology - Glioblastoma (GBM)

Phase 2

Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery

CompletedNCT00450372

University of MiamiMelanoma (Skin)

Start: 2004-06-30End: 2012-02-29Updated: 2017-02-08

GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent Glioblastoma (GBM)

RecruitingCTIS2024-511452-40-00

Global Coalition For Adaptive Research Inc.Oncology - Glioblastoma (GBM)

Start: 2025-09-12Target: 120Updated: 2025-09-12